CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 51 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $244,000 | 0.0% | 20,255 | +3.8% | 0.00% | – |
Q4 2018 | $244,000 | -10.9% | 19,505 | +5.3% | 0.00% | – |
Q3 2018 | $274,000 | -28.1% | 18,517 | -18.2% | 0.00% | – |
Q2 2018 | $381,000 | -26.7% | 22,642 | -0.4% | 0.00% | – |
Q1 2018 | $520,000 | -14.0% | 22,731 | -2.9% | 0.00% | -100.0% |
Q4 2017 | $605,000 | +199.5% | 23,417 | +71.0% | 0.00% | – |
Q3 2017 | $202,000 | -59.6% | 13,691 | -53.3% | 0.00% | – |
Q1 2017 | $500,000 | +46.6% | 29,327 | -11.6% | 0.00% | – |
Q4 2016 | $341,000 | -9.8% | 33,192 | -11.4% | 0.00% | – |
Q3 2016 | $378,000 | -3.6% | 37,454 | +7.3% | 0.00% | – |
Q2 2016 | $392,000 | +36.6% | 34,894 | +65.7% | 0.00% | – |
Q1 2016 | $287,000 | +4.4% | 21,055 | +45.4% | 0.00% | – |
Q4 2015 | $275,000 | -61.9% | 14,485 | -62.3% | 0.00% | -100.0% |
Q3 2015 | $721,000 | +78.5% | 38,415 | +41.4% | 0.00% | – |
Q2 2015 | $404,000 | -58.1% | 27,171 | -57.4% | 0.00% | -100.0% |
Q1 2015 | $965,000 | +193.3% | 63,753 | +158.5% | 0.00% | – |
Q4 2014 | $329,000 | +157.0% | 24,659 | +142.1% | 0.00% | – |
Q3 2014 | $128,000 | -26.4% | 10,187 | -21.1% | 0.00% | – |
Q1 2014 | $174,000 | – | 12,910 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |